Corient Private Wealth
SANA icon

Corient Private Wealth’s Sana Biotechnology SANA Stock Holding History

Corient Private Wealth’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.19M Sell
628,100
-14,000
-2% -$45.1K ﹤0.01% 1346
2026
Q1 		$1.85M Buy
642,100
+3,733
+0.6% +$14.7K ﹤0.01% 1317
2025
Q4 		$2.6M Sell
638,367
-178,633
-22% -$800K ﹤0.01% 1028
2025
Q3 		$2.9M Sell
817,000
-319,000
-28% -$1.15M ﹤0.01% 913
2025
Q2 		$3.1M Buy
1,136,000
+824,505
+265% +$1.7M ﹤0.01% 859
2025
Q1 		$523K Sell
311,495
-871,204
-74% -$2.44M ﹤0.01% 1576
2024
Q4 		$1.93M Buy
1,182,699
+730,699
+162% +$2.18M ﹤0.01% 1020
2024
Q3 		$1.88M Sell
452,000
-155,000
-26% -$814K ﹤0.01% 1131
2024
Q2 		$3.31M Buy
607,000
+269,537
+80% +$2.15M 0.01% 829
2024
Q1 		$3.37M Sell
337,463
-75,897
-18% -$569K 0.01% 818
2023
Q4 		$1.69M Buy
413,360
+130,500
+46% +$481K ﹤0.01% 1078
2023
Q3 		$1.09M Buy
282,860
+94,500
+50% +$508K ﹤0.01% 1158
2023
Q2 		$1.12M Buy
188,360
+85,000
+82% +$490K ﹤0.01% 1106
2023
Q1 		$338K Buy
103,360
+24,682
+31% +$98.6K ﹤0.01% 1557
2022
Q4 		$311K Buy
+78,678
New +$385K ﹤0.01% 1320

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Corient Private Wealth's SANA Position: Q2 2026 in Review

Corient Private Wealth reduced its Sana Biotechnology (SANA) stake by 2.2% in Q2 2026, selling an estimated $45.1K and leaving 628,100 shares worth $2.19M. The position accounts for ﹤0.01% of the portfolio, ranked #1346.

Corient Private Wealth first reported a position in SANA in Q4 2022 and has held it in 15 quarters since. The position peaked at $3.37M in Q1 2024. 212 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Corient Private Wealth held 628,100 shares of Sana Biotechnology worth $2.19M as of Q2 2026.
  • Corient Private Wealth sold 14,000 Sana Biotechnology shares in Q2 2026, an estimated $45.1K.
  • Sana Biotechnology made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1346 holding.
  • Corient Private Wealth first reported a position in Sana Biotechnology in Q4 2022 and has held it in 15 quarters since.
  • Corient Private Wealth's Sana Biotechnology position peaked at $3.37M in Q1 2024.
  • 212 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.